Related News Stories
VICTORIA: Vericiguat Seen as Novel Success in Tough-to-Treat, High-Risk Heart Failure
Rivaroxaban Plus Aspirin Safely Benefits PAD Patients After Limb Revascularization
REDUCE-IT: CV Benefit of Icosapent Ethyl Directly Related to EPA Levels
Follow theheart.org | Medscape Cardiology on Twitter
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Medscape Medical News © 2020
Cite this: American College of Cardiology Virtual Scientific Sessions 2020: Drug Therapy Highlights - Medscape - May 22, 2020.
Comments